Fosun Pharma USA Inc.

Fosun Pharma USA Inc. is a fast-growing pharmaceutical company focused on bringing products to market to improve patient access to medicine and innovation. Established in 2017 and headquartered in Princeton, New Jersey, it is a wholly owned subsidiary of Fosun Pharma (Group) co., Ltd., which was founded in 1994 and is headquartered in Shanghai. Fosun Pharma USA is a U.S.-focused specialty pharmaceutical company, innovating through strategic partnerships and building its commercial presence in the United States.

The company leverages its global parent company, Fosun Pharma Group, as well as a unique R&D model, to advance innovative products to patients in need. It is led by a team of highly experienced executives with a strong track record in both commercial operations and R&D at U.S. and European-based pharma companies. The current portfolio of Fosun Pharma USA includes specialty pharmaceutical injectable products and ophthalmics, aiming to build a portfolio of high value, branded innovative products.

Overall, Fosun Pharma USA Inc. presents an intriguing opportunity for venture capitalists looking to invest in a fast-growing pharmaceutical company with a focus on innovation and patient access to medicine. With its strong leadership team, strategic partnerships, and a growing portfolio of innovative products, the company has the potential to make a significant impact in the medical devices and pharmaceutical industries.